|
Group Post |
OVERVIEW: U.S. and international briefs-- AP and Reuters |
mike kraft |
|
Group Post |
White House shifts strategy to emphasize more testing to counter COVID spread |
mike kraft |
|
Group Post |
End of data sharing could make Covid-19 harder to control |
mike kraft |
|
Group Post |
Overview: COVID-19 International and U.S. developments |
mike kraft |
|
Group Post |
President Biden says the U.S. will work to scale up COVID vaccine production in other countries. |
mike kraft |
|
Group Post |
Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says |
mike kraft |
|
Group Post |
Europe's vaccine campaign is accelerating. It expects to match the U.S. by July. |
mike kraft |
|
Group Post |
Vaccinations could have prevented a fourth of US COVID-19 deaths: new analysis |
mike kraft |
|
Group Post |
Nevada Halts Use of Rapid Coronavirus Tests in Nursing Homes, Citing Inaccuracies |
mike kraft |
|
Group Post |
Cntact Tracing: How Germany and Israel respond in different ways |
mike kraft |
|
Group Post |
A variety of variants could fuel a winter COVID surge |
mike kraft |
|
Group Post |
BBC ANALYSIS: Covid-19 in the US: Is this coronavirus wave the worst yet? |
mike kraft |
|
Group Post |
Research Indicates Long COVID Now Looks like a Neurological Disease, Helping Shape Treatments |
mike kraft |
|
Group Post |
Vaccines are not being wasted in Africa, WHO official says |
mike kraft |
|
Group Post |
EU, Pfizer/BioNTech agree to cut COVID vaccine purchases |
mike kraft |
|
Group Post |
US to require all arriving passengers to get COVID-19 test |
mike kraft |
|
Group Post |
Merck’s new Covid-19 pill analysis: Looking at what is known and unknown |
mike kraft |
|
Group Post |
UK eyes mass testing, overview of other developments |
mike kraft |
|
Group Post |
Indian variant: UK may start vaccinating young people in hotspots, and how much faster does it spread? |
mike kraft |
|
Group Post |
FDA officials say annual Covid-19 shots may be needed in the future |
mike kraft |
|
Group Post |
Global rise in chronic diseases combined with Covid-19 bodes ill for world health |
mike kraft |
|
Group Post |
Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries--Lancet |
mike kraft |
|
Group Post |
What’s behind the early surge in RSV and flu — and what’s to come |
mike kraft |
|
Group Post |
White House testing czar promotes mask wearing, social distancing: 'Testing alone will never solve this issue' |
mike kraft |
|
Group Post |
U.S. FDA panel narrowly backs Pfizer RSV vaccine for older adults |
mike kraft |
Recent Comments